Cargando…
Treatment persistence of biologics among patients with psoriatic arthritis
BACKGROUND: Persistence of biologic therapy in psoriatic arthritis (PsA) patients is an important factor in individualized patient treatment planning and healthcare policy and guideline development. OBJECTIVE: To estimate the persistence of biologic agents prescribed to PsA patients in a real-life s...
Autores principales: | Haddad, Amir, Gazitt, Tal, Feldhamer, Ilan, Feld, Joy, Cohen, Arnon Dov, Lavi, Idit, Tatour, Faten, Bergman, Irena, Zisman, Devy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845003/ https://www.ncbi.nlm.nih.gov/pubmed/33514410 http://dx.doi.org/10.1186/s13075-021-02417-x |
Ejemplares similares
-
The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study
por: Gazitt, Tal, et al.
Publicado: (2022) -
Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
por: Haddad, Amir, et al.
Publicado: (2023) -
Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
por: Gazitt, Tal, et al.
Publicado: (2021) -
The epidemiology of psoriatic arthritis in Israel – a population-based study
por: Eder, Lihi, et al.
Publicado: (2018) -
The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis
por: Rahat, Michal A., et al.
Publicado: (2020)